Recent Innovations in the Management of Hepatocellular Cancer in the Setting of Liver Transplantation

Posted On 2018-02-28 09:25:11

Preface

Recent innovations in the management of hepatocellular cancer in the setting of liver transplantation: preface

Giovanni Battista Levi Sandri, Quirino Lai

Editorial

Twenty years after: from Milan criteria to a “blended” approach

Giovanni Battista Levi Sandri1, Quirino Lai

Review Article

The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution

Quirino Lai, Samuele Iesari, Fabio Melandro, Gianluca Mennini, Massimo Rossi, Jan Lerut

Review Article

Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review

Giovanni Battista Levi Sandri, Giuseppe Maria Ettorre, Valerio Giannelli, Marco Colasanti1, Rosa Sciuto, Giuseppe Pizzi, Roberto Cianni, Gianpiero D’Offizi, Mario Antonini, Giovanni Vennarecci, Pierleone Lucatelli

Review Article

Enlarged selection criteria for hepatocellular cancer: is the upper limit needed?

Andrea Peloso, Graziano Oldani

Review Article

Selection of patients with hepatocellular cancer: a difficult balancing between equity, utility, and benefit

Alessandro Vitale, Quirino Lai

Review Article

Hepatocellular carcinoma: when is liver transplantation oncologically futile?

André Viveiros, Heinz Zoller, Armin Finkenstedt

Review Article

Downstaging for hepatocellular cancer: harm or benefit?

Kathleen Bryce, Emmanuel A. Tsochatzis

Review Article

Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation

Russell E. Rosenblatt, Zaid H. Tafesh, Karim J. Halazun

Review Article

Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?

Davide Ghinolfi, Erion Rreka, Daniele Pezzati, Franco Filipponi, Paolo De Simone

Review Article

Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same?

Martina Coletta, Daniele Nicolini, Andrea Benedetti Cacciaguerra, Susanna Mazzocato, Roberta Rossi, Marco Vivarelli

Review Article

Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?

Roberta Angelico, Alessandro Parente, Tommaso Maria Manzia

Review Article

Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?

Rafael S. Pinheiro, Daniel R. Waisberg, Lucas S. Nacif, Vinicius Rocha-Santos, Rubens M. Arantes, Liliana Ducatti, Rodrigo B. Martino, Quirino Lai, Wellington Andraus, Luiz A. C. D’Albuquerque

Review Article

Single injection dual phase CBCT technique ameliorates results of trans-arterial chemoembolization for hepatocellular cancer

Pierleone Lucatelli, Renato Argirò, Stefano Bascetta, Luca Saba, Carlo Catalano, Mario Bezzi, Giovanni Battista Levi Sandri

Review Article

Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?

Jan Lerut, Samuele Iesari, Maxime Foguenne, Quirino Lai

Forward

Hepatocellualr cancer and liver transplantation: from the tower of babel towards a uniform language

Jan Lerut



Guest editor: Dr. Giovanni Battista Levi Sandri


Guest editor: Dr. Quirino Lai

Disclosure:
The series “Recent Innovations in the Management of Hepatocellular Cancer in the Setting of Liver Transplantation” was commissioned by the editorial office, Translational Gastroenterology and Hepatology without any sponsorship or funding. Giovanni Battista Levi Sandri, Quirino Lai served as the unpaid Guest Editors for the series.